Kraig Biocraft Laboratories (KBLB) Accounts Payables (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Accounts Payables across 16 years of filings, most recently posting $8.3 million for Q4 2025.

• Accounts Payables for Q4 2025 came in at $8.3 million, up 12.84% year-over-year; the trailing twelve-month figure through Dec 2025 was $8.3 million (up 12.84% YoY), and the FY2025 annual result was $8.3 million, up 12.84% from the prior year.
• Accounts Payables came in at $8.3 million for Q4 2025 at Kraig Biocraft Laboratories, up from $492252.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $8.3 million in Q4 2025 to a low of $286929.0 in Q1 2024.
• The 5-year median for Accounts Payables is $575440.0 (2021), against an average of $2.3 million.
• Peak annual rise in Accounts Payables reached 1263.12% in 2024, while the deepest fall reached 91.79% in 2024.
• Kraig Biocraft Laboratories' Accounts Payables stood at $587794.0 in 2021, then surged by 872.28% to $5.7 million in 2022, then plunged by 90.52% to $541637.0 in 2023, then soared by 1263.12% to $7.4 million in 2024, then rose by 12.84% to $8.3 million in 2025.
• The last three Accounts Payables figures came in at $8.3 million (Q4 2025), $492252.0 (Q3 2025), and $299485.0 (Q2 2025), per Business Quant data.